Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.

Source:http://linkedlifedata.com/resource/pubmed/id/19013107

Download in:

View as

General Info

PMID
19013107